$3.51
-0.11-3.16%
Pre-Market: Apr 4, 6:28 PM EDT
Comments
Loading...
Verve Therapeutics Insider Trading Activity | NASDAQ:VERV | Benzinga
Track the latest Verve Therapeutics insider trading activity. Stay informed on recent buys, sells, and market impact for Verve Therapeutics stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Verve Therapeutics Inc Insiders Doing?
At Verve Therapeutics Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of - shares worth -, meanwhile, insiders have report no purchases in the last 30 days.
Notable Recent Insider Buys and Sales
There has been no Insider buying or selling in the last 90 days.
Ownership Statistics for Verve Therapeutics Inc
Shares Outstanding
88.796M
Insider Shares Owned
1.141M
Insider Percentage Owned
1.29%
Institutional Shares Held
23.012M
Institutional Percentage Held
25.9%
| Apr 03, 2025 | Sekar Kathiresan | CHIEF EXECUTIVE OFFICER | 23.18K | $4.15 | -$40.76K | SELL-OPTIONS | 4.11% | 587.68K | Apr 01 - Apr 02 | View |
| Apr 03, 2025 | Joan Nickerson | CHIEF ADMINISTRATIVE OFFICER | 6.54K | $4.15 | -$11.52K | SELL-OPTIONS | 60.08% | 17.42K | Apr 01 - Apr 02 | View |
| Apr 03, 2025 | Andrew Ashe | SEE REMARKS | 6.32K | $4.15 | -$11.13K | SELL-OPTIONS | 1.84% | 348.83K | Apr 01 - Apr 02 | View |
| Apr 03, 2025 | Jason Politi | CHIEF TECHNICAL OPS. OFF. | 5.58K | $4.15 | -$13.43K | SELL-OPTIONS | 64.54% | 14.23K | Apr 01 - Apr 02 | View |
| Apr 03, 2025 | Allison Dorval | CHIEF FINANCIAL OFFICER | 7.90K | $4.15 | -$13.90K | SELL-OPTIONS | 146.84% | 13.28K | Apr 01 - Apr 02 | View |
| Apr 03, 2025 | Troy Lister | CHIEF SCIENTIFIC OFFICER | 5.15K | $4.15 | -$9.08K | SELL-OPTIONS | 286.01% | 6.95K | Apr 01 - Apr 02 | View |
| Dec 03, 2024 | Allison Dorval | CHIEF FINANCIAL OFFICER | 1.32K | $5.64 | -$3.13K | SELL-OPTIONS | 32.51% | 5.38K | Nov 29 - Dec 02 | View |
| May 15, 2024 | Andrew Ashe | SEE REMARKS | 76.00K | $6.26 | $475.76K | BUY | 28.52% | 342.51K | May 14 | View |
| Apr 03, 2024 | Joan Nickerson | CHIEF ADMINISTRATIVE OFFICER | 1.80K | $8.24 | -$12.48K | SELL-OPTIONS | 26.26% | 8.66K | Apr 01 - Apr 02 | View |
| Dec 05, 2023 | Krishna Yeshwant | — | 1.80M | $10.00 | $18.00M | BUY | 42.25% | 6.06M | Dec 01 | View |
| Dec 01, 2023 | Allison Dorval | CHIEF FINANCIAL OFFICER | 1.32K | $11.45 | -$6.34K | SELL-OPTIONS | 48.23% | 4.06K | Nov 29 | View |
| Dec 02, 2022 | Andrew Bellinger | CSO & CMO | -865.00 | $22.95 | -$19.85K | SELL | -11.54% | 6.63K | Dec 01 | View |
| Dec 01, 2022 | Allison Dorval | CHIEF FINANCIAL OFFICER | 1.32K | $22.10 | -$12.24K | SELL-OPTIONS | 152.72% | 2.19K | Nov 29 | View |
| Nov 08, 2022 | Krishna Yeshwant | DIRECTOR | -97.17K | $31.14 | -$1.51M | SELL | -2.23% | 4.26M | Nov 04 | View |
| Nov 08, 2022 | GV GP LLCGV GP LPGV LPGV GP LLCGV GP LPGV LPAlphabet Inc | — | -145.75K | $31.14 | -$3.03M | SELL | -3.31% | 4.26M | Nov 04 | View |
| Nov 04, 2022 | Krishna Yeshwant | DIRECTOR | -156.44K | $33.95 | -$2.66M | SELL | -3.50% | 4.31M | Nov 02 - Nov 03 | View |
| Nov 04, 2022 | GV GP LLCGV GP LPGV LPGV GP LLCGV GP LPGV LPAlphabet Inc | — | -234.66K | $33.95 | -$5.31M | SELL | -5.16% | 4.31M | Nov 02 - Nov 03 | View |
| Nov 02, 2022 | Krishna Yeshwant | DIRECTOR | -171.32K | $37.95 | -$3.25M | SELL | -3.76% | 4.39M | Oct 31 - Nov 01 | View |
| Nov 02, 2022 | GV GP LLCGV GP LPGV LPGV GP LLCGV GP LPGV LPAlphabet Inc | — | -256.98K | $37.95 | -$6.50M | SELL | -5.53% | 4.39M | Oct 31 - Nov 01 | View |
| Nov 01, 2022 | Andrew Bellinger | CSO & CMO | 0.00 | $20.69 | -$384.20K | SELL-OPTIONS | 0.00% | 6.63K | Oct 28 | View |
| Oct 05, 2022 | Sekar Kathiresan | CHIEF EXECUTIVE OFFICER | 0.00 | $17.52 | -$1.61M | SELL-OPTIONS | 0.00% | 398.84K | Oct 03 | View |
| Sep 27, 2022 | Andrew Bellinger | CSO & CMO | 0.00 | $18.41 | -$2.03M | SELL-OPTIONS | 0.00% | 6.63K | Sep 23 | View |
| Aug 11, 2022 | Sekar Kathiresan | CHIEF EXECUTIVE OFFICER | 0.00 | $15.64 | -$1.43M | SELL-OPTIONS | 0.00% | 398.84K | Aug 10 | View |
| Jul 22, 2022 | Andrew Bellinger | CSO & CMO | 0.00 | $18.14 | -$670.20K | SELL-OPTIONS | 0.00% | 6.63K | Jul 20 | View |
| Jul 21, 2022 | Sekar Kathiresan | CHIEF EXECUTIVE OFFICER | 0.00 | $15.64 | -$1.43M | SELL-OPTIONS | 0.00% | 398.84K | Jul 19 | View |
| Jul 15, 2022 | Andrew Bellinger | CSO & CMO | 0.00 | $13.19 | -$234.20K | SELL-OPTIONS | 0.00% | 6.63K | Jul 13 | View |
| Jul 14, 2022 | FMR LLC | 10% OWNER | -163.00K | $20.78 | -$3.39M | SELL | -22.22% | 570.73K | Jul 12 | View |
| Jul 06, 2022 | FMR LLC | 10% OWNER | -38.77K | $15.66 | -$607.22K | SELL | -4.77% | 773.73K | Jul 01 | View |
| Jul 01, 2022 | FMR LLC | 10% OWNER | -53.22K | $15.45 | -$822.48K | SELL | -6.45% | 772.50K | Jun 29 - Jun 30 | View |
| May 13, 2022 | Burt Adelman | DIRECTOR | 10.00K | $12.15 | $121.53K | BUY | 2.39% | 428.33K | May 12 | View |
| Mar 17, 2022 | Burt Adelman | DIRECTOR | 4.00K | $21.38 | $85.54K | BUY | 0.97% | 418.33K | Mar 15 | View |
| Mar 11, 2022 | FMR LLC | 10% OWNER | -3.97K | $29.01 | -$115.20K | SELL | -0.48% | 825.72K | Mar 09 | View |
| Feb 11, 2022 | FMR LLC | 10% OWNER | -13.19K | $29.46 | -$388.58K | SELL | -1.56% | 829.69K | Feb 09 | View |
| Feb 03, 2022 | FMR LLC | 10% OWNER | -35.57K | $29.04 | -$1.03M | SELL | -4.05% | 842.88K | Feb 01 | View |
| Jan 28, 2022 | FMR LLC | 10% OWNER | -158.84K | $31.12 | -$4.94M | SELL | -15.31% | 878.46K | Jan 26 - Jan 27 | View |
| Jan 06, 2022 | Sekar Kathiresan | CHIEF EXECUTIVE OFFICER | 0.00 | $20.64 | -$72.01K | SELL-OPTIONS | 0.00% | 487.53K | Jan 04 | View |
| Dec 29, 2021 | Sekar Kathiresan | CHIEF EXECUTIVE OFFICER | 0.00 | $20.78 | -$1.89M | SELL-OPTIONS | 0.00% | 487.53K | Dec 27 - Dec 28 | View |
| Dec 27, 2021 | Andrew Bellinger | CHIEF SCIENTIFIC OFFICER | 0.00 | $20.09 | -$558.27K | SELL-OPTIONS | 0.00% | 5.00K | Dec 22 | View |
| Dec 27, 2021 | Sekar Kathiresan | CHIEF EXECUTIVE OFFICER | 0.00 | $20.35 | -$4.32M | SELL-OPTIONS | 0.00% | 487.53K | Dec 22 - Dec 23 | View |
| Dec 06, 2021 | Andrew Ashe | SEE REMARKS | 4.00K | $32.10 | $128.42K | BUY | 2.40% | 170.72K | Dec 02 | View |
| Dec 06, 2021 | Burt Adelman | DIRECTOR | 4.70K | $31.34 | $147.30K | BUY | 1.15% | 414.33K | Dec 02 | View |
| Jun 23, 2021 | Redmile Group LLCJeremy Green | 10% OWNER | 1.94M | $19.00 | $19.95M | BUY | ∞ | 1.94M | Jun 21 | View |
| Jun 23, 2021 | Cormorant Asset Management LPBihua ChenCormorant Global Healthcare Master Fund LPCormorant Private Healthcare Fund III LP | DIRECTOR | 984.22K | $19.00 | $5.22M | BUY | ∞ | 984.22K | Jun 21 | View |
| Jun 22, 2021 | Logos Global Management LP | 10% OWNER | 813.26K | $19.00 | $7.03M | BUY | ∞ | 370.00K | Jun 21 | View |
| Jun 22, 2021 | Rock Springs Capital Management LPRock Springs Capital Master Fund LPRock Springs Capital LLC | 10% OWNER | 1.08M | $19.00 | $7.03M | BUY | ∞ | 152.93K | Jun 21 | View |
| Jun 22, 2021 | Peter Haahr Chief Financial Officer of Novo Holdings A/S | 10% OWNER | 793.26K | $19.00 | $6.65M | BUY | ∞ | 793.26K | Jun 21 | View |
| Jun 22, 2021 | Casdin Partners Master Fund LP | 10% OWNER | 2.42M | $19.00 | $20.90M | BUY | ∞ | 2.42M | Jun 21 | View |
| Jun 21, 2021 | Margaret Beaudoin | VICE PRESIDENT, FINANCE | 1.00K | $19.00 | $19.00K | BUY | ∞ | 1.00K | Jun 21 | View |
| Jun 21, 2021 | Andrew Bellinger | CHIEF SCIENTIFIC OFFICER | 5.00K | $19.00 | $95.00K | BUY | ∞ | 5.00K | Jun 21 | View |
| Jun 21, 2021 | Sekar Kathiresan | CHIEF EXECUTIVE OFFICER | 2.50K | $19.00 | $47.50K | BUY | 0.52% | 487.53K | Jun 21 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.